OUR COMPANY | Technology-Sharing Initiative

Technology-Sharing Initiative

Rising to an unprecedented challenge toward a world free from all diseases

Where it starts

Our vision of a world
free from all diseases

Our vision brought to life with the Technology-Sharing Initiative

It is a challenge today for any diagnostics company to release multiple new products per year.

We believe the broad range of products developed through Seegene’s Technology-Sharing Initiative will help combat future pandemics and enable earlier detection and prevention of diseases.

“Guided by this belief, we are confident that every living being can move closer to a life free from diseases.

In essence

In 2023, we launched the Technology-Sharing Initiative to connect the world through syndromic PCR.

We plan to share our syndromic PCR technologies and automated development solutions with our partner companies and scientists to proactively develop and deliver innovative, accessible syndromic PCR assays across diverse fields.

How are we leading the way?

We have built a comprehensive diagnostic product development solution composed of our core capabilities and proprietary syndromic PCR technologies.
Through the Technology-Sharing Initiative, we share these solutions with partners worldwide.

Seegene provides each global partner with a comprehensive package including :

Technology

Seegene's unique syndromic PCR
assay technology

Seegene's syndromic PCR assay technology with the ability
to multiplex 15 targets with Ct values in a single tube

Tech-Sharing Tool

Automated development tool for sharing technology with scientists and experts worldwide

(Seegene Digitalized Development System, SGDDS)

CURECA™

Seegene's World-first Fully Automated and Modular PCR Testing System

Seegene is developing fully automated PCR testing system that covers the entire workflow, from pre-treatment stage to result analysis. Its modular design ensures accessibility for laboratories worldwide.

Global Partnerships for
NewCos

How is it going so far?

With the goal of creating a global network to build a healthier society and sustainable future,
we have also begun partnerships with leading companies.

We plan to expand this network to include representative partners from more than a hundred countries.

Through the Technology-Sharing Initiative, partner companies will locally develop and
distribute diagnostic products via newly established entities, or NewCos.

Strategic Collaborations

How is it
going so far?

We believe this vision of “a world free from all diseases” is unachievable by the effort of a single company.
This vision can only be realized by channeling the collective wisdom and
capabilities of scientists, experts, and companies toward this singular goal.

We are backed by strategic collaborations with Microsoft and Springer Nature, both globally renowned leaders in
IT solutions and scientific research, respectively.

Open Innovation Program
Network
Seegene and Springer
Nature Announce
Strategic Alliance
Strategic alliance aims to foster collaboration with researchers working in various disease fields by using best-in-class PCR diagnostic technology
Building a Future Free from
All Disease Through
Syndromic PCR
Equipping scientists and experts with 25years of Seegene’s know-how in superior syndromic PC technologies, along with automated development solutions and instruments.
Azure
Seegene Announces
Collaboration with
Microsoft
Digitally enhance Seegene's automated diagnostic reagent development system with the integration of Microsoft Azure AI solutions